Your browser doesn't support javascript.
loading
ID1 mediates resistance to osimertinib in EGFR T790M-positive non-small cell lung cancer through epithelial-mesenchymal transition.
Liu, Kejun; Chen, Xianwen; Wu, Ligang; Chen, Shiyuan; Fang, Nianxin; Cai, Limin; Jia, Jun.
Afiliación
  • Liu K; Dongguan Institute of Clinical Cancer Research, Affiliated Dongguan People's Hospital, Southern Medical University, Dongguan, China.
  • Chen X; Department of Pathology, Gaozhou People's Hospital, Maoming, China.
  • Wu L; Dongguan Institute of Clinical Cancer Research, Affiliated Dongguan People's Hospital, Southern Medical University, Dongguan, China.
  • Chen S; Dongguan Institute of Clinical Cancer Research, Affiliated Dongguan People's Hospital, Southern Medical University, Dongguan, China.
  • Fang N; Dongguan Institute of Respiratory and Critical Care Medicine, Affiliated Dongguan People's Hospital, Southern Medical University, Dongguan, China. 24588883@qq.com.
  • Cai L; Dongguan Institute of Clinical Cancer Research, Affiliated Dongguan People's Hospital, Southern Medical University, Dongguan, China. dgcailimin@163.com.
  • Jia J; Dongguan Institute of Clinical Cancer Research, Affiliated Dongguan People's Hospital, Southern Medical University, Dongguan, China. jiwen6465@126.com.
BMC Pulm Med ; 21(1): 163, 2021 May 15.
Article en En | MEDLINE | ID: mdl-33992097
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Acrilamidas / Carcinoma de Pulmón de Células no Pequeñas / Resistencia a Antineoplásicos / Proteína 1 Inhibidora de la Diferenciación / Compuestos de Anilina / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: BMC Pulm Med Año: 2021 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Acrilamidas / Carcinoma de Pulmón de Células no Pequeñas / Resistencia a Antineoplásicos / Proteína 1 Inhibidora de la Diferenciación / Compuestos de Anilina / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: BMC Pulm Med Año: 2021 Tipo del documento: Article País de afiliación: China